Pricing

TetraLogic Pharmaceuticals Corp (TLOG)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Tony Meehan
Employees:
10
P.O. BOX 1305, PAOLI, NY, 19301
610-889-9900

Are you looking for this stock instead?

TetraLogic Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company, which is focused on discovering and developing novel small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development: Birinapant, and SHAPE. Birinapant is designed to mimic the activity of an endogenous protein, the Second Mitochondrial Activator of Caspases, which is involved in the regulation of the apoptotic process within cells. SHAPE is a histone deacetylase inhibitor that the company is developing for topical use for the treatment of cancer. The company was founded by John M. Gill and Mark A. McKinlay in July 2001 and is headquartered in Malvern, PA.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available